154 related articles for article (PubMed ID: 28374695)
1. [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke].
Sazonov IE; Kudinov AA; Fedotova EP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):64-67. PubMed ID: 28374695
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].
Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615
[TBL] [Abstract][Full Text] [Related]
4. [The use of cytoflavin in the acute period of hemorrhagic stroke].
Sazonov IE; Klementenko TD; Kudinov AA; Avramenko MA; Yarmonov SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(2):23-26. PubMed ID: 29560936
[TBL] [Abstract][Full Text] [Related]
5. [Modern methods of energy homeostasis correction in elderly patients].
Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN
Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy of metabolic treatment in the early recovery period of patients with ischemic stroke].
Poltavskaya TS; Bazhenov VA; Volojanin AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):49-53. PubMed ID: 32307430
[TBL] [Abstract][Full Text] [Related]
7. [The use of cytoflavin in reperfusion in ischemic stroke].
Sazonov IE; Lavrenteva IV; Golovina NP
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(3):25-28. PubMed ID: 27070468
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of cytoflavin in patients in the acute ischemic stroke].
Odinak MM; Skvortsova VI; Vozniuk IA; Rumiantseva SA; Stakhovskaia LV; Klocheva EG; Novikova LB; Ianishevskiĭ SN; Golokhvastov SIu; Tsygan NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):29-36. PubMed ID: 21311484
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
[TBL] [Abstract][Full Text] [Related]
10. [Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
Muratov FK; Shermukhamedova FK; Batocyrenov BV; Haritonova TV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):44-47. PubMed ID: 28139625
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
Beĭn BN; Dravert NE
Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
[TBL] [Abstract][Full Text] [Related]
12. [The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):53-5. PubMed ID: 25176268
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
[TBL] [Abstract][Full Text] [Related]
14. Early predictive blood markers of hemorrhagic stroke - influence of cytoflavin therapy.
Silina EV; Rumyantceva SA; Stupin VA; Parfenov VA; Bolevich SB
Can J Physiol Pharmacol; 2021 Jan; 99(1):72-79. PubMed ID: 32910863
[TBL] [Abstract][Full Text] [Related]
15. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
[TBL] [Abstract][Full Text] [Related]
16. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP
Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233
[TBL] [Abstract][Full Text] [Related]
18. [THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Klin Med (Mosk); 2015; 93(2):67-71. PubMed ID: 26117922
[TBL] [Abstract][Full Text] [Related]
19. [The use of cytoflavin in sports nutrition].
Kosinets VA; Stolbitskiĭ VV; Shturich IP
Klin Med (Mosk); 2012; 90(7):56-8. PubMed ID: 23019978
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the Cytoflavin on the distal polyneuropathy severity in patients with diabetic foot syndrome with arteries mediacalcinosis].
Skripko VD; Kovalenko AL; Zaplutanov VA
Khirurgiia (Mosk); 2017; (8):75-78. PubMed ID: 28805783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
